Provident Investment Management, Inc. Gilead Sciences, Inc. Transaction History

Provident Investment Management, Inc.

$1.04 Billion
Q2 2024

A detailed history of Provident Investment Management, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Provident Investment Management, Inc. holds 14,000 shares of GILD stock, worth $1.17 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

14,000

Previous 14,000 -0.0%

Holding current value

$1.17 Million

Previous $1.03 Million 6.34%

% of portfolio

0.09%

Previous 0.1%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $98,035 - $111,174	-1,338 Reduced 8.72%	14,000 $1.13 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $83,384 - $119,710	1,338 Added 9.56%	15,338 $1.32 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $752,960 - $943,540	-13,000 Reduced 48.15%	14,000 $832,000
Q2 2021 Aug 06, 2021	SELL	$63.47 - $69.35 $660,088 - $721,239	-10,400 Reduced 27.81%	27,000 $1.86 Million
Q1 2021 May 10, 2021	SELL	$60.0 - $68.46 $3.47 Million - $3.96 Million	-57,877 Reduced 60.75%	37,400 $2.42 Million
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $23.2 Million - $26.5 Million	-409,878 Reduced 81.14%	95,277 $5.55 Million
Q3 2020 Nov 05, 2020	BUY	$62.1 - $78.08 $624,663 - $785,406	10,059 Added 2.03%	505,155 $31.9 Million
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $9.22 Million - $10.7 Million	127,488 Added 34.68%	495,096 $38.1 Million
Q1 2020 May 04, 2020	SELL	$62.63 - $80.22 $6.62 Million - $8.48 Million	-105,719 Reduced 22.34%	367,608 $27.5 Million
Q4 2019 Feb 10, 2020	BUY	$61.62 - $67.78 $64,331 - $70,762	1,044 Added 0.22%	473,327 $30.8 Million
Q3 2019 Nov 06, 2019	BUY	$62.51 - $69.0 $2.65 Million - $2.92 Million	42,388 Added 9.86%	472,283 $29.9 Million
Q2 2019 Aug 08, 2019	BUY	$61.87 - $69.38 $3.06 Million - $3.44 Million	49,518 Added 13.02%	429,895 $29 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $355,858 - $398,654	5,691 Added 1.52%	380,377 $24.7 Million
Q4 2018 Feb 11, 2019	SELL	$60.54 - $79.0 $1.67 Million - $2.18 Million	-27,601 Reduced 6.86%	374,686 $23.4 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $219,114 - $242,600	-3,074 Reduced 0.76%	402,287 $31.1 Million
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $1.02 Million - $1.19 Million	15,707 Added 4.03%	405,361 $28.7 Million
Q1 2018 Apr 23, 2018	BUY	$72.84 - $88.8 $501,357 - $611,210	6,883 Added 1.8%	389,654 $29.4 Million
Q4 2017 Feb 06, 2018	BUY	$71.15 - $83.52 $121,879 - $143,069	1,713 Added 0.45%	382,771 $27.4 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $27.5 Million - $32.6 Million	381,058	381,058 $30.9 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Provident Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Provident Investment Management, Inc. with notifications on news.

Account

Provident Investment Management, Inc. Gilead Sciences, Inc. Transaction History